Analysts Viewpoint AKBA’s latest rating updates from top analysts. Akebia Therapeutics Inc’s filing revealed that its Officer Ostrowski Erik acquired Company’s shares for reported $0.15 million on Jun 30
Insiders Updates Analysts predict AKBA shares will perform strongly in 2023 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akebia Therapeutics
Stock Earnings H.C. Wainwright’s latest rating for AKBA stock Akebia Therapeutics Inc’s filing revealed that its SVP, Chief Accounting Officer Malabre Richard C unloaded Company’s shares for reported $60150.0
Analysts Viewpoint Akebia Therapeutics Inc [AKBA] Shares Jump Approximately 234.86% Over the Year Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akebia Therapeutics